Eads & Heald Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$433K Sell
1,480
-28
-2% -$9.2K 0.22% 119
2025
Q4
$529K Buy
1,508
+277
+23% +$93.6K 0.26% 110
2025
Q3
$398K Buy
1,231
+390
+46% +$121K 0.19% 121
2025
Q2
$327K Buy
+841
New +$338K 0.16% 122

Other funds holding ELV

Eads & Heald Wealth Management's ELV Position: Q1 2026 in Review

Eads & Heald Wealth Management reduced its Elevance Health (ELV) stake by 1.9% in Q1 2026, selling an estimated $9.2K and leaving 1,480 shares worth $433K. The position accounts for 0.22% of the portfolio, ranked #119.

Eads & Heald Wealth Management first reported a position in ELV in Q2 2025 and has held it in 4 quarters since. The position peaked at $529K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Eads & Heald Wealth Management held 1,480 shares of Elevance Health worth $433K as of Q1 2026.
  • Eads & Heald Wealth Management sold 28 Elevance Health shares in Q1 2026, an estimated $9.2K.
  • Elevance Health made up 0.22% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #119 holding.
  • Eads & Heald Wealth Management first reported a position in Elevance Health in Q2 2025 and has held it in 4 quarters since.
  • Eads & Heald Wealth Management's Elevance Health position peaked at $529K in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.